Navigation Links
DrugRisk Announces Addition of Januvia Cancer Resource Center
Date:4/18/2013

New York, NY (PRWEB) April 18, 2013

The prescription drug safety advocates at DrugRisk.com are announcing the launch of a new resource center for patients who have taken the diabetes drug Januvia, amid warnings that the drug may be related to pancreatic cancer and thyroid cancer.

The goal of DrugRisk is to improve patient safety by providing those taking prescription drugs with the latest warnings, recalls, studies and legal news. Patients can see if others are experiencing similar side effects and decide if they need legal advice.

Januvia is a once-a-day pill introduced in 2006 to help those with type-2 diabetes control blood sugar. It has become Merck’s best-selling drug, with sales over $4 billion last year*.

However, DrugRisk has added a 2011 study from UCLA indicating the drug could increase the risk of pancreatic cancer by 272% and thyroid cancer by 148%**. The Journal for the American Medical Association also recently published findings showing Januvia could double the risk of pancreatitis, which is a risk factor for pancreatic cancer***.

Now, DrugRisk has learned that, with the number of patients filing a Januvia lawsuit alleging cancer growing, lawyers have requested that cases be consolidated to a special federal multi-district court in California****. (In Re: Incretins Products Liability, Sales and Marketing Litigation, MDL 2452, United States Judicial Panel on Multidistrict Litigation).

Anyone affected by cancer after taking Januvia is encouraged to speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugRisk only recommends lawyers who have already handled Januvia lawsuits.

For more informati
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
2. DrugRisk Announces Alternative to Mirena IUD May Be Available Soon
3. DrugRisk Announces Updated Information on Mirena Lawsuits
4. DrugRisk Adds Latest Health Warnings and Lawsuit Updates for Yaz
5. DrugRisk Announces New Pradaxa Health Warning From Australia
6. DrugRisk Update: NuvaRing Lawsuit Trials to Begin This Year
7. DrugRisk Update: Court Allows Charges of Prior Fraud Into Pradaxa Lawsuit
8. DrugRisk Pradaxa Lawsuit Update: Court Denys Boehringer’s Protective Order Request
9. DrugRisk Pradaxa Update: Litigation Grows As New Study Adds to Risks
10. DrugRisk Update: Bayer Discloses $500 Million Remaining for Yaz Lawsuits
11. DrugRisk Update: Evidence Submitted in Actos Lawsuit Suggests Drug Maker Knew of Cancer Risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... Today, Zane Benefits, the #1 Online Health Benefits ... radio show. , According to Zane Benefits, health ... doesn’t make sense to choose a “one size fits ... and employee as much as 60 percent on health ... Speaking on Business , Chris Redgrave, highlights the rising ...
(Date:9/15/2014)... UC San Francisco researchers have used brain scans to ... a possible tool to spot children with dyslexia and ... , In the United States, children usually learn to ... proficient readers by third grade, according to the authors. ... kindergarteners as they were learning to read formally at ...
(Date:9/15/2014)... from the prospective Prostate, Lung, Colorectal and Ovarian (PLCO) ... baldness affecting both the front and the crown of ... increased risk of developing aggressive prostate cancer (usually indicates ... to non-aggressive prostate cancer) later in life, compared to ... between other patterns of baldness and prostate cancer risk. ...
(Date:9/15/2014)... 2014 In order to provide predictability ... act conjointly to quantify, define and model medical practice. ... integral part of medical care. , The Journal of ... conducted by the non-profit Institute of BioAcoustic Biology, located ... math can be much more than a measurement tool; ...
(Date:9/15/2014)... Amy Norton HealthDay ... A relatively small number of medications are responsible for sending ... a U.S. government study finds. Each year between 2007 ... were hospitalized after getting a hold of family members, medication, ... "Three-quarters of those children were just 1 or ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Featured on Zions Bank Speaking on Business 2Health News:Study first to use brain scans to forecast early reading difficulties 2Health News:Certain form of baldness at age 45 linked to higher risk of aggressive prostate cancer 2Health News:Math as Medicine: The Promise of Frequency Domain BioMarkers as a Template to Predict, Enchance and Promote Optimal Health 2Health News:Math as Medicine: The Promise of Frequency Domain BioMarkers as a Template to Predict, Enchance and Promote Optimal Health 3Health News:Small Number of Drugs Behind Kids' Accidental Poisonings: CDC 2Health News:Small Number of Drugs Behind Kids' Accidental Poisonings: CDC 3
... survival rate of non-small-cell lung cancer patients after ... Cisplatin is an anti-neoplastic medication that interferes with ... growth and spread in the body. ... three or four cycles of cisplatin-based chemotherapy or ...
... the world's first epilepsy drug, an Australian neurologist says.// ... a mild sedative, taken either as a herbal infusion ... form. ,But the Italian author Fabio Colonna first ... botanical work Phytobasanos. ,Colonna said he had controlled ...
... around 700,000 people researchers say dads who have children ... // for developing schizophrenia later in life. ... to the hospital in Sweden between 1989 and 2001 ... Researchers say they found a strong association between the ...
... recent study shows that people who use stomach-acid suppressive ... may be at an increased risk of developing pneumonia ... the stomach can increase vulnerability to infections, as stomach ... Researchers studied pneumonia rates of more than 364,000 patients ...
... study researchers say they have found that the drug ... cancer // decreased patients' cancer incidence after 12 months ... some impact, but the 20-milligram dose had the greatest ... prostatic intraepithelial neoplasia, characterized by abnormal cells in the ...
... New research shows that sleep disorders may be linked ... ADD ), // neuromuscular conditions, and psychiatric problems. ... patients with sleep apnea also had ADD. Results also ... insomnia. Further testing showed some of these patients also ...
Cached Medicine News:Health News:Valerian was first epilepsy drug 2
(Date:9/15/2014)... , Sept. 15, 2014 /PRNewswire-iReach/ -- Asthma ... persons of all ages, but most commonly starts ... characterized by narrowing of the airways, leading to ... lungs come into contact with endogenous and exogenous ... events, such as swelling of the airways, tightening ...
(Date:9/15/2014)... MedicOne Medical Response, a leading provider emergency and ... Inc. Magazine as one of the fastest growing ... - http://photos.prnewswire.com/prnh/20140914/145997 The ... with the largest revenue growth between 2010 and ... ambulance companies to make the list, achieved an ...
(Date:9/15/2014)... -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ... 2014, regular quarterly dividend payment of $0.15 per share ... September 5, 2014, the record date. About ... of patents and royalty assets, consisting primarily of its ... with various biotechnology and pharmaceutical companies. PDL pioneered the  ...
Breaking Medicine Technology:Asthma Market to Reach 161.02 million Cases in 10MM by 2023 2Asthma Market to Reach 161.02 million Cases in 10MM by 2023 3Asthma Market to Reach 161.02 million Cases in 10MM by 2023 4Asthma Market to Reach 161.02 million Cases in 10MM by 2023 5MedicOne Medical Response Named to 2014 Inc. 5000 Fastest Growing Companies List 2MedicOne Medical Response Named to 2014 Inc. 5000 Fastest Growing Companies List 3PDL BioPharma Completes Regular Quarterly Dividend Payment 2
... 11, 2011 Vanda Pharmaceuticals Inc. (NASDAQ: ... Corporation, an affiliate of Vanda,s sublicensor Novartis Pharma ... the long-acting injectable (or depot) formulation of Fanapt® ... will evaluate the safety and pharmacokinetic profiles of ...
... 11, 2011 Merck (NYSE: MRK ), ... and Intercell AG (VSE: ICLL) today announced that following ... trial evaluating V710, an investigational vaccine for the prevention ... Monitoring Committee (DMC) recommended suspension of enrollment. Although the ...
Cached Medicine Technology:Vanda Pharmaceuticals Announces Commencement of Clinical Study of Long-Acting Injectable Formulation of Fanapt® 2Vanda Pharmaceuticals Announces Commencement of Clinical Study of Long-Acting Injectable Formulation of Fanapt® 3Update on Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710 2Update on Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710 3
...
...
... exercise BP monitor is designed to automatically ... diastolic BP along with heart rate. It's ... use in treadmill, ergometer and pharmacological stress ... use in research environments., ,Tango excels ...
...
Medicine Products: